NF-κB functions as a tumour promoter in inflammation-associated cancer

Eli Pikarsky (), Rinnat M. Porat, Ilan Stein, Rinat Abramovitch, Sharon Amit, Shafika Kasem, Elena Gutkovich-Pyest, Simcha Urieli-Shoval, Eithan Galun and Yinon Ben-Neriah ()
Additional contact information
Eli Pikarsky: Hadassah-Hebrew University Medical Center
Rinnat M. Porat: Hadassah-Hebrew University Medical Center
Ilan Stein: Hadassah-Hebrew University Medical Center
Rinat Abramovitch: Goldyne Savad Institute of Gene Therapy
Sharon Amit: Hebrew University-Hadassah Medical School
Shafika Kasem: Hadassah-Hebrew University Medical Center
Elena Gutkovich-Pyest: Hebrew University-Hadassah Medical School
Simcha Urieli-Shoval: Hadassah University Hospital
Eithan Galun: Goldyne Savad Institute of Gene Therapy
Yinon Ben-Neriah: Hebrew University-Hadassah Medical School

Nature, 2004, vol. 431, issue 7007, 461-466

Abstract: Abstract The causes of sporadic human cancer are seldom recognized, but it is estimated that carcinogen exposure and chronic inflammation are two important underlying conditions for tumour development, the latter accounting for approximately 20% of human cancer1. Whereas the causal relationship between carcinogen exposure and cancer has been intensely investigated2, the molecular and cellular mechanisms linking chronic inflammation to tumorigenesis remain largely unresolved1. We proposed that activation of the nuclear factor κB (NF-κB), a hallmark of inflammatory responses3 that is frequently detected in tumours4,5, may constitute a missing link between inflammation and cancer. To test this hypothesis, we studied the Mdr2-knockout mouse strain, which spontaneously develops cholestatic hepatitis followed by hepatocellular carcinoma6, a prototype of inflammation-associated cancer7. We monitored hepatitis and cancer progression in Mdr2-knockout mice, and here we show that the inflammatory process triggers hepatocyte NF-κB through upregulation of tumour-necrosis factor-α (TNFα) in adjacent endothelial and inflammatory cells. Switching off NF-κB in mice from birth to seven months of age, using a hepatocyte-specific inducible IκB-super-repressor transgene, had no effect on the course of hepatitis, nor did it affect early phases of hepatocyte transformation. By contrast, suppressing NF-κB inhibition through anti-TNFα treatment or induction of IκB-super-repressor in later stages of tumour development resulted in apoptosis of transformed hepatocytes and failure to progress to hepatocellular carcinoma. Our studies thus indicate that NF-κB is essential for promoting inflammation-associated cancer, and is therefore a potential target for cancer prevention in chronic inflammatory diseases.

Date: 2004
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/nature02924 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:431:y:2004:i:7007:d:10.1038_nature02924

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/nature02924

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().